Aurinia Pharmaceuticals (AUPH) Raw Materials (2023 - 2026)
Aurinia Pharmaceuticals' (AUPH) quarterly Raw Materials came in at $658000.0 in Q1 2026, down 14.66% YoY from $771000.0 in Q1 2025, and little changed on a QoQ basis from $658000.0 in Q4 2025.
Aurinia Pharmaceuticals (AUPH) Raw Materials (2023 - 2026) Analysis & Trends
Aurinia Pharmaceuticals (AUPH) has 4 years of Raw Materials data on file, last reported at $658000.0 in Q1 2026.
- Quarterly Raw Materials fell 14.66% year-over-year to $658000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $658000.0 (down 14.66% YoY) and the FY2025 annual result came in at $658000.0, down 61.34% from the prior year.
- Raw Materials was little changed at $658000.0 in Q1 2026, from $658000.0 in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $1.7 million in Q4 2023 to a low of $658000.0 in Q4 2025.
- A 4-year average of $1.0 million and a median of $771000.0 in 2025 frame the typical range for Raw Materials.
- Annual changes were most pronounced in 2024 — Raw Materials fell 2.52% — and 2025, when it sank 61.34%.
- Tracing AUPH's Raw Materials over 4 years: stood at $1.7 million in 2023, then decreased by 2.52% to $1.7 million in 2024, then plunged by 61.34% to $658000.0 in 2025, then changed by 0.0% to $658000.0 in 2026.
- The last three Raw Materials figures came in at $658000.0 (Q1 2026), $658000.0 (Q4 2025), and $771000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Aurinia Pharmaceuticals | 2.06 Bn | 1.61 Bn | 76.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 658,000.00 |
| Mar 31, 2026 | 658,000.00 |
| Dec 31, 2025 | 658,000.00 |
| Sep 30, 2025 | 771,000.00 |
| Jun 30, 2025 | 771,000.00 |
| Mar 31, 2025 | 771,000.00 |
| Dec 31, 2024 | 1.70 Mn |
| Dec 31, 2023 | 1.75 Mn |